Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries

Journal of Infectious Diseases

Volumn 212, Issue 4, 2015, Pages 570-577

  Cambiano, Valentina ^a   Ford, Deborah ^b   Mabugu, Travor ^e   Napierala Mavedzenge, Sue ^g   Miners, Alec ^c   Mugurungi, Owen ^f   Nakagawa, Fumiyo ^a   Revill, Paul ^d   Phillips, Andrew ^a  

^a Research Department of Infection and Population Health   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^g RTI INTERNATIONAL   (United States)

Author keywords

cost effectiveness; diagnostic; HIV; mathematical modeling; self testing

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISABILITY; EPIDEMIC; HEALTH CARE COST; HEALTH CARE PERSONNEL; HIV TEST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERMETHOD COMPARISON; NONHUMAN; PATIENT CARE; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; PROVIDER-DELIVERED HIV TESTING AND COUNSELING; REPEAT PROCEDURE; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; TREND STUDY; ZIMBABWE; BIOLOGICAL MODEL; DEVELOPING COUNTRY; ECONOMICS; HEALTH; HIV INFECTIONS; POVERTY; PREVALENCE; SELF CARE; STATISTICS; TIME;

ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; POVERTY; PREVALENCE; SELF CARE; STOCHASTIC PROCESSES; TIME FACTORS; ZIMBABWE;

EID: 84939626138     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv040     Document Type: Article

References (31)

1. Staveteig S, Wang S, Head SK, Bradley SEK, Nybro E. Demographic patterns of HIV testing uptake in Sub-Saharan Africa. DHS Comparative Reports 30. Calverton, MD: ICF International, 2013.
2. WHO/UNAIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organization, 2007. http://whqlibdoc.who.int/publications/2007/9789241595568-eng.pdf. Accessed 12 October 2013.
3. Report on the first international symposium on self-testing for HIV: the legal, ethical, gender, human rights and public health implications of HIV self-testing scale-up. Geneva:World Health Organization, 2013.
4. Napierala Mavedzenge S, Baggaley R, Corbett EL. A review of self-testing for HIV: research and policy priorities in a new era of HIV prevention. Clin Infect Dis 2013; 57:126-38.
5. Pant Pai N, Sharma J, Shivkumar S, et al. Supervised and unsupervised self-testing for HIV in high-and low-risk populations: a systematic review. PLoS Med 2013; 10:e1001414.
6. Choko AT, Desmond N, Webb EL, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a crosssectional feasibility study in Blantyre, Malawi. PLoS Med 2011; 8: e1001102.
7. Corbett EL. Uptake, accuracy and linkage into care following access to community-based self-testing for HIV in Malawi. Presented at: The legal, ethical, gender, human rights and public health implications of self-testing scale-up, Geneva, Switzerland, 8-9 April 2013.
8. MacPherson P, Lalloo D, Choko A, et al. Home assessment and initiation of ART following HIV self-testing: a cluster-randomised trial to improve linkage to ART in Blantyre, Malawi. 2013.
9. Kalibala S, Tun W, Muraah W, Cherutich P, Oweya E, Oluoch P. Knowing myself first': feasibility of self-testing among health workers in Kenya. Nairobi, Kenya: Population Council, 2011. http://www.popcouncil.org/pdfs/2011HIVKenyaHWSelfTesting.pdf. Accessed 5 April 2013.
10. Choko AT, MacPherson P, Webb EL, et al. One year outcomes following community-based HIV self-testing: a prospective study in Malawi. Presented at: 21st Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 3-6 March 2014.
11. Cambiano V, Bertagnolio S, Jordan MR, Lundgren JD, Phillips A. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. J Infect Dis 2013; 207(suppl 2):S57-62.
12. Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 2008; 371:1443-51.
13. Phillips AN, Pillay D, Garnett G, et al. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS 2011; 25:843-50.
14. Phillips AN, Sabin C, Pillay D, Lundgren JD. HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy. HIV Med 2007; 8:536-46.
15. Zimbabwe National Statistics Agency, MEASURE DHS, ICF Macro. Zimbabwe Demographic and Health Survey 2010-11: preliminary report. Harare, Zimbabwe: Zimbabwe national Statistics Agency, 2011.
16. US Food and Drug administration. First rapid home-use HIV kit approved for self-testing, 2012. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm310545.htm. Accessed 5 March 2013.
17. Asiimwe S, Oloya J, Song X, Whalen CC. Accuracy of un-supervised versus provider-supervised self-administered HIV testing in Uganda: a randomized implementation trial. AIDS Behav 2014; 18:2477-84.
18. Gaydos CA, Hsieh YH, Harvey L, et al.Will patients "opt in" to perform their own rapid HIV test in the emergency department? Ann Emerg Med 2011; 58(1 suppl 1):S74-8.
19. Pant Pai N, Behlim T, Abrahams L, et al. Will an unsupervised self-testing strategy for HIV work in health care workers of South Africa? A cross sectional pilot feasibility study. PLoS One 2013; 8: e79772.
20. Jaspard M, Le MG, Saberan-Roncato M, et al. Finger-stick whole blood HIV-1/-2 home-use tests are more sensitive than oral fluid-based in-home HIV tests. PLoS One 2014; 9:e101148.
21. Pant Pai N, Balram B, Shivkumar S, et al. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:373-80.
22. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8:e1001056.
23. Fonner VA, Denison J, Kennedy CE, O'Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev 2012; 9: CD001224.
24. National Medicine and Therapeutics Policy Advisory Committee (NMTPAC) and The AIDS and TB Directorate Ministry of Health and Child Care, Zimbabwe. Guidelines for antiretroviral therapy for the prevention and treatment of HIV in Zimbabwe. Harare, Zimbabwe: NMTPAC, 2013.
25. World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO, 2013. http://www.who.int/hiv/pub/guidelines/arv2013/en/index.html. Accessed 15 July 2013.
26. Edejer T-T, Baltussen R, Hutubessy HR, Acharya A, Evans DB, Murray CJL. Making choices in health: WHO guide to cost effectiveness analysis. Geneva: World Health Organization, 2003. http://www.who.int/choice/publications/p-2003-generalised-cea.pdf. Accessed 15 October 2013.
27. Eaton JW, Menzies NA, Stover J, et al. Health benefits, costs, and costeffectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health 2014; 2:e23-34.
28. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380:2129-43.
29. World Health Organization (WHO). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: WHO, 2007. http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. Accessed 8 July 2013.
30. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Oxford, United Kingdom: Oxford University Press, 2005.
31. UNICEF, United Nations Programme on HIV/AIDS, WHO, MSF. Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS. 76th ed. Geneva: WHO, 2005. http://www. unaids.org/en/media/unaids/contentassets/dataimport/publications/ircpub02/jc645sourcespricesen.pdf. Accessed 25 October 2013.